Rallybio Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rallybio Corporation (RLYB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-57.78-74.56-66.65-47.01-26.45
Depreciation & Amortization0.130.150.170.110.06
Stock Based Compensation7.9910.929.503.650.70
Change in Working Capital-0.264.28-0.94-3.782.12
Change in Accounts Payable-0.70-0.100.49-0.980.72
Change in Other Working Capital-1.61-3.09-1.42-2.801.40
Other Operating Activities-1.61-3.099.503.650.00
Net Cash from Operating Activities-49.28-60.27-57.28-45.53-22.04
Investing Activities
Capital Expenditures0.00-0.01-0.050.33-0.14
Acquisitions-2.00-2.25-0.30-2.000.00
Purchases of Investments-48.93-108.41-112.12-2.00-1.94
Sales/Maturities of Investments84.43138.33-111.820.000.00
Net Cash from Investing Activities33.4927.66-112.17-2.33-2.07
Financing Activities
Common Stock Issued5.410.2851.7786.20145.21
Other Financing Activities-0.27-0.14-0.69-3.23-0.32
Net Cash from Financing Activities5.200.1451.0882.97144.89
Summary
Net Change in Cash-10.59-32.46-118.3835.10120.78
Cash at Beginning of Period24.4956.96175.33140.230.00
Cash at End of Period13.9024.4956.96175.330.00
Free Cash Flow-49.28-60.28-57.34-45.87-22.18